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3,5-Di-tert-butyl-2-hydroxybenzaldehyde (84 mg, 0.36 mmol) was added slowly to a stirring 
solution of 4,6-di(1-methylhydrazino)pyrimidine (30 mg, 0.18 mmol) in MeOH (1 mL).  The 
yellow solution was stirred under argon at reflux for 1 hour before cooling to ambient temperature.  
The resulting lemon slurry was filtered and washed with cold methanol to yield 68mg of a white 
powder (0.11 mmol, 61% yield).  1H NMR (CDCl3, 700 MHz): 11.50 (2H, s, HOH), 8.54 (1H, s, H3), 
7.99 (2H, s, Himine), 7.33 (2H, d, J = 2.5, H5'), 7.11 (2H, d, J = 2.5, H3'), 6.78 (1H, s, H6), 3.67 (6H, s, 
HNMe), 1.41 (18H, s, H8'), 1.33 (18H, s, H10'). 13C NMR (CDCl3, 176 MHz): 162.2 (C2), 157.6 (C6), 
154.5 (C1'), 143.6 (Cimine), 140.9 (C4'), 136.8 (C6'), 125.8 (C5'), 125.5 (C3'), 117.9 (C2'), 86.2 (C3), 
35.3 (C9'), 34.3 (C7'), 31.7 (C10'), 30.4 (CNMe), 29.8 (C8'). MS (ES+): m/z 601 [M+H]+; HRMS 
(ES+): m/z 601.4253 [M+H]+; calculated for [C36H53N6O2]+ 601.4230.  
 




H2L7 (30 mg, 0.05 mmol) and [Ir(dpyx)Cl(µ-Cl)]2 (26 mg, 0.025 mmol) were heated to 195°C in 
ethylene glycol (1.5 mL) for 90 min under argon.  The resulting slurry was allowed to cool to 
ambient temperature, then H2O (5 mL) was added and an orange-brown solid isolated by filtration.  
This material was dissolved in the minimum volume of hot DMSO and added dropwise into a 
saturated aqueous solution of KPF6.  The resulting precipitate was separated by centrifugation and 
washed with H2O to yield the yellow mononuclear complex (29 mg, 0.024 mmol, 48% yield).  
1H NMR (CD3CN, 700 MHz): 11.37 (1H, s), 8.92 (1H, s), 8.20 (2H, d, J = 8), 8.16 (1H, s), 7.82 – 
7.78 (4H, m), 7.55 (1H, d, J = 2.5), 7.42 (1H, d, J = 2), 7.32 (1H, d, J = 2), 7.22 (1H, d, J = 3), 7.15 
(1H, s), 7.11 (1H, s), 7.04 (2H, ddd, J = 7, 5 and 1), 6.58 (1H, s), 4.10 (3H, s), 3.48 (3H, s), 1.49 
(9H, s), 1.30 (18H, s), 0.70 (9H, s). 13C NMR (CD3CN, 176 MHz): 171.2, 159.9, 159.6, 159.4, 
158.9, 155.3, 151.4, 142.6, 141.8, 141.6, 140.4, 139.3, 139.2, 137.6, 137.3, 132.3, 130.1, 128.6, 
127.5, 127.3, 124.6, 123.5, 119.3, 118.7, 118.3, 84.8, 35.9, 35.8, 34.9, 34.6, 33.6, 31.7, 31.7, 30.6, 
29.8, 29.2, 22.5. MS (ES+): m/z 1052 [M+H]+; HRMS (ES+): m/z 1049.4940 [M]+; calculated for 
[C54H66N8O2Ir]+ 1049.4915. 
  













Figure S1  Crystal packing in the ditopic proligands H2L5 (left) and H2L7 (right).    Hydrogen 




Figure S2  Crystal packing for the complex [Ir(dpyx)L4]PF6, with H atoms omitted for clarity. 
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Figure S4  The molecular structure (left) and crystal packing (right) of the dinuclear 
complexes [{Ir(dpyx)2}L6](PF6)2 (top) and [{Ir(dpyF)2}L6](PF6)2 (bottom); hydrogen atoms 
omitted for clarity. 
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Table S1 Selected bond lengths and angles in the mono- and dinuclear iridium(III) 













Ir1–C 1.948(2)   1.971(10) 1.952(5) 1.945(9)  
Ir1–N(hyd) 2.078(1) 2.066(8) 2.079(5) 2.076(7) 
Ir1–N(py[m]NNO) 2.019(1) 2.017(7) 2.027(5) 2.025(7) 
Ir1–N4(pyNCN) 2.035(1) 2.049(9) 2.045(5) 2.057(7) 
Ir1–N5(pyNCN) 2.053(1) 2.023(8) 2.051(5) 2.051(8) 
Ir1–O 2.033(1) 2.013(7) 2.026(4) 2.024(6) 
Ir2–C  1.966(9) 1.947(5) 1.945(9)  
Ir2–N(hyd)  2.074(7) 2.079(5) 2.068(7) 
Ir2–N(pym)  2.007(8) 2.029(5) 1.997(7) 
Ir2–N9(pyNCN)  2.051(8) 2.053(5) 2.021(8) 
Ir2–N10(pyNCN)  2.073(8) 2.055(5) 2.057(7) 
Ir2–O  2.036(7) 2.029(4) 2.008(6) 
N4-Ir1-N5 161.42(6) 161.3(4) 160.9(2) 159.2(3) 
N(pym)-Ir1-O 171.70(5) 172.1(3) 171.6(2) 171.6(3) 
N(hyd)-Ir1-C 175.57(6)   177.7(4) 176.0(2) 177.0(3)  
N9-Ir2-N10  161.2(3) 160.4(2) 161.2(3) 
N(pym)-Ir2-O  171.5(3) 171.4(2) 172.0(3) 
N(hyd)-Ir2-C  176.2(3) 178.2(2) 178.6(3)  
Ir1⋅⋅⋅Ir2 8.804 (b) 5.984 (c) 6.021 (c) 5.943 (c) 
 
(a) N(hyd) = hydrazone nitrogen; N(pym) = pyrimidine nitrogen; N(py[m]NNO) = nitrogen of the pyridine ring of 
the N^N^O ligand for [Ir(dpyx)L4]+ and nitrogen of the pyrimidine ring bonded to Ir1 for the dinuclear 
complexes.  (b) Intermolecular Ir⋅⋅⋅Ir distance.  (c) Intramolecular Ir⋅⋅⋅Ir distance. 
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Figure S5  Comparison of the emission spectra of the mononuclear complexes 
[Ir(dpyx)L1]PF6 and [Ir(dpyx)HL5]PF6 with that of dinuclear [{Ir(dpyx)}2L5](PF6)2 in 
CH2Cl2 at 295 K, showing the 0,1 vibrational component to be more intense than the 0,0 for 
the mononuclear complexes and vice versa for the dinuclear complex. 
	  
	  
Figure S6  Absorption and emission spectra of [Ir(dpyx)HL7]PF6 in CH2Cl2 at 295 K 
(black and red lines respectively) and the emission spectrum in EPA at 77 K (blue line).  
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NMR Spectra 
 
Figure S7 1H NMR (700 MHz, CDCl3) spectrum of H2L5. 
 
Figure S8 13C NMR (176 MHz, CDCl3) spectrum of H2L5. 
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Figure S9 1H NMR (700 MHz, CDCl3) spectrum of H2L6. 
 
 
Figure S10 1H NMR (700 MHz, DMSO-d6) spectrum of [Ir(dpyx)L1]PF6. 
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Figure S11 13C NMR (176 MHz, DMSO-d6) spectrum of [Ir(dpyx)L1]PF6. 
 
 
Figure S12 1H NMR (700 MHz, CD3CN) spectrum of [Ir(dpyx)L2]PF6. 
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Figure S13 13C NMR (176 MHz, CD3CN) spectrum of [Ir(dpyx)L2]PF6. 
 
 
Figure S14 1H NMR (700 MHz, CD3CN) spectrum of [Ir(dpyx)L3]PF6. 
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Figure S15 13C NMR (176 MHz, CD3CN) spectrum of [Ir(dpyx)L3]PF6. 
 
 
Figure S16 1H NMR (700 MHz, CD3CN) spectrum of [Ir(dpyx)L4]PF6. 
- 12 - 
 
Figure S17 13C NMR (176 MHz, CD3CN) spectrum of [Ir(dpyx)L4]PF6. 
 
 
Figure S18 1H NMR (700 MHz, CD3CN) spectrum of [Ir(dpyx)HL5]PF6. 
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Figure S19 13C NMR (176 MHz, CD3CN) spectrum of [Ir(dpyx)HL5]PF6. 
 
 
Figure S20 1H NMR (700 MHz, CD3CN) spectrum of [Ir(dpyx)HL6]PF6. 
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Figure S21 13C NMR (176 MHz, CD3CN) spectrum of [Ir(dpyx)HL6]PF6. 
 
 
Figure S22 1H NMR (700 MHz, CD3CN) spectrum of [Ir(dpyF)HL6]PF6. 
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Figure S23 1H NMR (700 MHz, CD3CN) spectrum of [{Ir(dpyx)}2L5](PF6)2. 
 
 
Figure S24 13C NMR (176 MHz, CD3CN) spectrum of [{Ir(dpyx)}2L5](PF6)2. 
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Figure S25 1H NMR (700 MHz, CD3CN) spectrum of [{Ir(dpyx)}2L6](PF6)2. 
 
Figure S26 13C NMR (176 MHz, CD3CN) spectrum of [{Ir(dpyx)}2L6](PF6)2. 
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Figure S27 1H NMR (700 MHz, CD3CN) spectrum of [{Ir(dpyF)}2L6](PF6)2. 
 
